These features allow very sensitive, accurate, and fast diagnostic responses from graphene-based biosensors, electrochemical and optical biosensors have shown results in enhancing the detection of key cancer biomarkers, i.e., carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), and cancer-related exosomes. This evidence concerns the gene CEACAM5 and cancer.